Head and Neck Cancer Trial, Recruiting NCT06085781 Sponsor: University Health Network, Toronto Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06085781
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed with head and neck squamous cell carcinoma (a type of cancer affecting the head and neck area), confirmed through a tissue sample test
  • People whose cancer (either the main tumour or affected lymph nodes) is larger than 3cm
  • People who are reasonably well and able to carry out daily activities (based on a standard fitness scale used in cancer care, rated 0–2)
  • People whose treatment plan includes surgery or radiation therapy (with or without chemotherapy) aimed at curing the cancer
  • People who are willing to have repeat MRI scans as part of the study
  • People who are able to understand spoken and written information about the study and can sign a consent form
  • People whose kidneys are functioning well enough (based on a blood test result)
  • People who are able to lie flat on their back comfortably for about one hour

Who may not be able to join:

  • People who, in the opinion of the study doctor, have other serious illnesses that make participation unsuitable
  • People who have a medical reason why they cannot have MRI scans
  • People who have had another solid tumour (a type of cancer) that was treated within the last 5 years
  • People who are pregnant
  • People who have previously had an allergic reaction to gadolinium contrast dye (a substance sometimes used in MRI scans)
  • People who have a blood clotting disorder that cannot be corrected or reversed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 January 2024
Est. completion
15 January 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in tumor microenvironment during radiotherapy; Change in fMRI during radiotherapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov